Company profile: BrightInsight
1.1 - Company Overview
Company description
- Provider of a global regulated digital health platform for biopharma and medtech. Offers the BrightInsight Platform to develop, launch, and scale digital health solutions, including companion apps, algorithms, and SaMD; the Hizentra medication management app; professional digital health services for software development and data management; the Digital Health C-Suite Series; and a go-to-market strategies white paper.
Products and services
- BrightInsight Platform: Regulated digital health platform for biopharma and medtech to develop, launch, and scale products such as companion apps, algorithms, and SaMD
- Professional Digital Health Services: Professional-grade services that create or implement digital health products, encompassing software development and data management
- Hizentra App: Medication-specific patient app that offers reminders, record management, and infusion tracking for individuals taking Hizentra
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BrightInsight
Silicon Therapeutics
HQ: United States
Website
- Description: Provider of fully integrated drug design, research and development using a physics-driven approach coupled to chemistry and biology R&D, with a pipeline including VTAMA (Tapinarof) for plaque psoriasis; Batoclimab for autoimmune diseases (MG, TED, CIDP, Graves' Disease); IMVT-1402 (Phase 1) subcutaneous injection; Brepocitinib for dermatomyositis and non-infectious uveitis (Phase 3 for some applications); and Namilumab for sarcoidosis (Phase 2).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silicon Therapeutics company profile →
Datatrak
HQ: United States
Website
- Description: Provider of DATATRAK ONE® Unified Experience™, removing clinical research complexities and accelerating the ultimate outcome of every trial.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Datatrak company profile →
Immunai
HQ: United States
Website
- Description: Provider of immunology mapping and reprogramming solutions leveraging machine learning and software engineering, including AMICA—a comprehensive immune cell knowledge base integrating clinico-genomic data; single-cell analysis and functional genomics; and drug discovery and development support from target discovery and validation through compound validation and clinical trial optimization, with biopharma and academic partnerships contributing data back to AMICA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Immunai company profile →
CLC Bio
HQ: Denmark
Website
- Description: Provider of bioinformatics solutions focused on analyzing data from all major high-throughput sequencing machines, including instruments from Illumina, Applied Biosystems (LIFE Technologies), Roche 454, Helicos, and Sanger.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CLC Bio company profile →
GQ Life Sciences
HQ: United States
Website
- Description: Provider of life science information and search solutions: GenomeQuest, a patent search tool for DNA, RNA, and protein sequences with comprehensive comparison algorithms and a large indexed sequence database; and LifeQuest, a life science patent search platform using ontologies to understand biological queries and deliver complete, relevant results without false positives from non-life science patents.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GQ Life Sciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BrightInsight
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BrightInsight
2.2 - Growth funds investing in similar companies to BrightInsight
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BrightInsight
4.2 - Public trading comparable groups for BrightInsight
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →